PET tracer C-11 4DST outperforms FDG in detecting cell proliferation

01/2/2012 | AuntMinnie.com (free registration)

The PET imaging agent C-11 4DST performed better than the standard PET agent FDG in detecting proliferation of cancer cells in patients with nonsmall-cell lung cancer, according to a Japanese study presented at a radiology meeting. PET/CT imaging with C-11 4DST can also allow for a noninvasive view of DNA synthesis in the disease, the researchers said. The C-11 4DST tracer can help differentiate between benign and malignant tissues, determine tumor activity, assess response to treatment and improve prediction of patient prognosis, a researcher said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ